Clinical spectrum of high-titre GAD65 antibodies

OBJECTIVE: To determine clinical manifestations, immunotherapy responsiveness and outcomes of glutamic acid decarboxylase-65 (GAD65) neurological autoimmunity. METHODS: We identified 323 Mayo Clinic patients with high-titre (>20 nmol/L in serum) GAD65 antibodies out of 380 514 submitted anti-GAD6...

Descripción completa

Detalles Bibliográficos
Autores principales: Budhram, Adrian, Sechi, Elia, Flanagan, Eoin P, Dubey, Divyanshu, Zekeridou, Anastasia, Shah, Shailee S, Gadoth, Avi, Naddaf, Elie, McKeon, Andrew, Pittock, Sean J, Zalewski, Nicholas L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Neuro-Inflammation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142435/
https://www.ncbi.nlm.nih.gov/pubmed/33563803
http://dx.doi.org/10.1136/jnnp-2020-325275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142435/
https://www.ncbi.nlm.nih.gov/pubmed/33563803
http://dx.doi.org/10.1136/jnnp-2020-325275

Ejemplares similares